About 5AM Solutions

What We Do

5AM Solutions is a provider of cloud-based solutions for life sciences and healthcare. For 14 years, 5AM has been a software product developer and system integrator for life science and healthcare customers who were early adopters and providers of genomic technologies. We have offered customers unique methods for leveraging genomics to address the data challenges of integrating personalized medicine into all sectors of health care.

Our software and services facilitate:

  • Integration of data from disparate information systems to target therapies
  • Leveraging virtually unlimited external data sources to drive drug discovery
  • Exceptionally strong management of big data, especially genetic data
  • Collaborations and partnerships that involve sharing proprietary data
  • Privacy protections for patients’ information

Our executive team spent 6 months in 2015 visiting current and prospective clients and discovered some of the greatest and continually growing challenges for Pharma, Hospitals, Universities, and Biotechnology firms:

  • “Our data scientists have no time to analyze data because they spend all their time fixing and manually integrating data.”
  • “We’re capturing medical, trial and observational data from the same patients and still can’t mine the combined data because they’re in different systems.”
  • “I have electronic medical records but no good way to assemble patient cohorts for research studies.”
  • “We’re overwhelmed by the volume, complexity and noisiness of genomic and medical data.”

To address these needs, 5AM created 5AM Sunrise™, a unique platform that allows organizations to clean, analyze, and visualize genomic, clinical trial and observational data.

5AM is creating a platform to address the exponentially growing need for the design, aggregation, analysis and visualization of genomic, clinical and observational data.

Three areas are targeted: observational data management; data analysis, curation, and visualization; and interfaces for patient engagement tools.

diagram of Sunrise API platform

The Precision Medicine technology business is estimated at $40B today with 10.5% CAGR. 5AM projects approximately 10% of this market will be satisfied by 5AM Sunrise™ and supports an ecosystem of analytics, stand alone products, and large enterprise providers with strong vertical offerings.

Precision Medicine will drown the current capability of organizations to incorporate genetic data and clinical trial data. Adding observational data on patients using mobile and wearable technologies adds to the complexity and problems. This is required for Precision Medicine to become mainstream.

Earl M. Furfine, CPA, PMP, CITP, Chief Executive Officer. Earl has been a founder or partner in seven technology start-ups, with a proven track record of accelerated growth and successful acquisitions and exits. He has a Masters in Management from the J.L. Kellogg School of Management, Northwestern University and a Bachelor of Science in Accountancy from the University of Illinois, Urbana-Champaign.

Brent Gendleman, Founder and Executive for Business Development - Brent Gendleman leverages a diverse, 20-year background in consulting, technology and publishing to advance 5AM’s ability to help customers address the data challenges of integrating personalized medicine into all sectors of health care.

William FitzHugh, Chief Science Officer - William FitzHugh has over 20 years of experience crafting software solutions to interesting problems, especially in the field of molecular biology. Will has a Master of Science in Computer Science from Boston University and a Bachelor of Arts in Mathematics from Cornell University.

Shilpa Gorfine, Senior Vice President of Operations and Finance - Shilpa has built a highly successful track record of driving innovation and financial success within organizations across the healthcare industry. She holds a Masters in Business Administration and in Public Health from Johns Hopkins University and a Bachelor of Arts in Business Economics from Brown University.

John Jones, Chief Technology Officer. John is a recognized expert in pharmaceutical technology requirements and solutions. Prior to joining 5AM, John led Quintiles’ IT Consulting Division from 2010-2016 focusing on IT Advisory and Implementation services. John has more than 20 years of IT experience in the clinical, regulatory, and commercial areas.